Emerging roles of Cdk8 in cell cycle control

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1829, Issue 9, 2013, Pages 916-920

  Szilagyi, Zsolt ^a   Gustafsson, Claes M ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Differentiation; Mediator; Mitosis; Protein stability; Stem cells; Wnt catenin signaling

Indexed keywords

CYCLIN DEPENDENT KINASE 8; MEDIATOR COMPLEX;

CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; HUMAN; MAMMAL CELL; MITOSIS; MITOTIC CONTROL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TRANSCRIPTION REGULATION; YEAST;

DIFFERENTIATION; MEDIATOR; MITOSIS; PROTEIN STABILITY; STEM CELLS; WNT/Β-CATENIN SIGNALING;

CELL CYCLE; CYCLIN-DEPENDENT KINASE 8; RNA POLYMERASE II; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84878832875     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2013.04.010     Document Type: Review

References (67)

1. Kelleher R.J., Flanagan P.M., Kornberg R.D. A novel mediator between activator proteins and the RNA polymerase II transcription apparatus. Cell 1990, 61:1209-1215.
2. Kim Y.J., Bjorklund S., Li Y., Sayre M.H., Kornberg R.D. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell 1994, 77:599-608.
3. Malik S., Roeder R.G. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat. Rev. Genet. 2010, 11:761-772.
4. Conaway R.C., Conaway J.W. Origins and activity of the Mediator complex. Semin. Cell Dev. Biol. 2011, 22:729-734.
5. Myers L.C., Gustafsson C.M., Bushnell D.A., Lui M., Erdjument-Bromage H., Tempst P., Kornberg R.D. The Med proteins of yeast and their function through the RNA polymerase II carboxy-terminal domain. Genes Dev. 1998, 12:45-54.
6. Egloff S., Dienstbier M., Murphy S. Updating the RNA polymerase CTD code: adding gene-specific layers. Trends Genet. 2012, 28:333-341.
7. Robinson P.J., Bushnell D.A., Trnka M.J., Burlingame A.L., Kornberg R.D. Structure of the Mediator Head module bound to the carboxy-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:17931-17935.
8. Soutourina J., Wydau S., Ambroise Y., Boschiero C., Werner M. Direct interaction of RNA polymerase II and mediator required for transcription in vivo. Science 2011, 331:1451-1454.
9. Thompson C.M., Koleske A.J., Chao D.M., Young R.A. A multisubunit complex associated with the RNA polymerase II CTD and TATA-binding protein in yeast. Cell 1993, 73:1361-1375.
10. Samuelsen C.O., Baraznenok V., Khorosjutina O., Spahr H., Kieselbach T., Holmberg S., Gustafsson C.M. TRAP230/ARC240 and TRAP240/ARC250 Mediator subunits are functionally conserved through evolution. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6422-6427.
11. Elmlund H., Baraznenok V., Lindahl M., Samuelsen C.O., Koeck P.J., Holmberg S., Hebert H., Gustafsson C.M. The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:15788-15793.
12. Knuesel M.T., Meyer K.D., Bernecky C., Taatjes D.J. The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. Genes Dev. 2009, 23:439-451.
13. Galbraith M.D., Donner A.J., Espinosa J.M. CDK8: a positive regulator of transcription. Transcription 2010, 1:4-12.
14. Conaway R.C., Conaway J.W. Function and regulation of the Mediator complex. Curr. Opin. Genet. Dev. 2011, 21:225-230.
15. Davis M.A., Larimore E.A., Fissel B.M., Swanger J., Taatjes D.J., Clurman B.E. The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with Mediator. Genes Dev. 2013, 27:151-156.
16. Welcker M., Clurman B.E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 2008, 8:83-93.
17. Massague J. G1 cell-cycle control and cancer. Nature 2004, 432:298-306.
18. Donner A.J., Szostek S., Hoover J.M., Espinosa J.M. CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol. Cell 2007, 27:121-133.
19. Reinhardt H.C., Schumacher B. The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet. 2012, 28:128-136.
20. Porter D.C., Farmaki E., Altilia S., Schools G.P., West D.K., Chen M., Chang B.D., Puzyrev A.T., Lim C.U., Rokow-Kittell R., Friedhoff L.T., Papavassiliou A.G., Kalurupalle S., Hurteau G., Shi J., Baran P.S., Gyorffy B., Wentland M.P., Broude E.V., Kiaris H., Roninson I.B. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:13799-13804.
21. Clayton J.E., van den Heuvel S.J., Saito R.M. Transcriptional control of cell-cycle quiescence during C. elegans development. Dev. Biol. 2008, 313:603-613.
22. Niehrs C., Acebron S.P. Mitotic and mitogenic Wnt signalling. EMBO J. 2012, 31:2705-2713.
23. Talluri S., Dick F.A. Regulation of transcription and chromatin structure by pRB: here, there and everywhere. Cell Cycle 2012, 11:3189-3198.
24. Bernards R. Cancer: entangled pathways. Nature 2008, 455:479-480.
25. Firestein R., Bass A.J., Kim S.Y., Dunn I.F., Silver S.J., Guney I., Freed E., Ligon A.H., Vena N., Ogino S., Chheda M.G., Tamayo P., Finn S., Shrestha Y., Boehm J.S., Jain S., Bojarski E., Mermel C., Barretina J., Chan J.A., Baselga J., Tabernero J., Root D.E., Fuchs C.S., Loda M., Shivdasani R.A., Meyerson M., Hahn W.C. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 2008, 455:547-551.
26. Seo J.O., Han S.I., Lim S.C. Role of CDK8 and beta-catenin in colorectal adenocarcinoma. Oncol. Rep. 2010, 24:285-291.
27. Kim S., Xu X., Hecht A., Boyer T.G. Mediator is a transducer of Wnt/beta-catenin signaling. J. Biol. Chem. 2006, 281:14066-14075.
28. Firestein R., Shima K., Nosho K., Irahara N., Baba Y., Bojarski E., Giovannucci E.L., Hahn W.C., Fuchs C.S., Ogino S. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival. Int. J. Cancer 2010, 126:2863-2873.
29. Kaur M., Velmurugan B., Tyagi A., Agarwal C., Singh R.P., Agarwal R. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling. Neoplasia 2010, 12:415-424.
30. Roychowdhury S., Iyer M.K., Robinson D.R., Lonigro R.J., Wu Y.M., Cao X., Kalyana-Sundaram S., Sam L., Balbin O.A., Quist M.J., Barrette T., Everett J., Siddiqui J., Kunju L.P., Navone N., Araujo J.C., Troncoso P., Logothetis C.J., Innis J.W., Smith D.C., Lao C.D., Kim S.Y., Roberts J.S., Gruber S.B., Pienta K.J., Talpaz M., Chinnaiyan A.M. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci. Transl. Med. 2011, 3:111ra121.
31. Polakis P. Drugging Wnt signalling in cancer. EMBO J. 2012, 31:2737-2746.
32. Morris E.J., Ji J.Y., Yang F., Di Stefano L., Herr A., Moon N.S., Kwon E.J., Haigis K.M., Naar A.M., Dyson N.J. E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 2008, 455:552-556.
33. Wong J.V., Dong P., Nevins J.R., Mathey-Prevot B., You L. Network calisthenics: control of E2F dynamics in cell cycle entry. Cell Cycle 2011, 10:3086-3094.
34. Zhao J., Ramos R., Demma M. CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation. Oncogene 3 September 2012, (advance online publication, in press). 10.1038/onc.2012.364.
35. Spellman P.T., Sherlock G., Zhang M.Q., Iyer V.R., Anders K., Eisen M.B., Brown P.O., Botstein D., Futcher B. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol. Biol. Cell 1998, 9:3273-3297.
36. McInerny C.J. Cell cycle regulated gene expression in yeasts. Adv. Genet. 2011, 73:51-85.
37. Cross F.R., Buchler N.E., Skotheim J.M. Evolution of networks and sequences in eukaryotic cell cycle control. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2011, 366:3532-3544.
38. Cosma M.P., Panizza S., Nasmyth K. Cdk1 triggers association of RNA polymerase to cell cycle promoters only after recruitment of the mediator by SBF. Mol. Cell 2001, 7:1213-1220.
39. Cosma M.P., Tanaka T., Nasmyth K. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell 1999, 97:299-311.
40. Bhoite L.T., Yu Y., Stillman D.J. The Swi5 activator recruits the Mediator complex to the HO promoter without RNA polymerase II. Genes Dev. 2001, 15:2457-2469.
41. Mocciaro A., Rape M. Emerging regulatory mechanisms in ubiquitin-dependent cell cycle control. J. Cell Sci. 2012, 125:255-263.
42. Kishi T., Ikeda A., Koyama N., Fukada J., Nagao R. A refined two-hybrid system reveals that SCF(Cdc4)-dependent degradation of Swi5 contributes to the regulatory mechanism of S-phase entry. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14497-14502.
43. Chi Y., Huddleston M.J., Zhang X., Young R.A., Annan R.S., Carr S.A., Deshaies R.J. Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase. Genes Dev. 2001, 15:1078-1092.
44. Salghetti S.E., Caudy A.A., Chenoweth J.G., Tansey W.P. Regulation of transcriptional activation domain function by ubiquitin. Science 2001, 293:1651-1653.
45. Buck V., Ng S.S., Ruiz-Garcia A.B., Papadopoulou K., Bhatti S., Samuel J.M., Anderson M., Millar J.B., McInerny C.J. Fkh2p and Sep1p regulate mitotic gene transcription in fission yeast. J. Cell Sci. 2004, 117:5623-5632.
46. Rustici G., Mata J., Kivinen K., Lio P., Penkett C.J., Burns G., Hayles J., Brazma A., Nurse P., Bahler J. Periodic gene expression program of the fission yeast cell cycle. Nat. Genet. 2004, 36:809-817.
47. Whitfield M.L., Sherlock G., Saldanha A.J., Murray J.I., Ball C.A., Alexander K.E., Matese J.C., Perou C.M., Hurt M.M., Brown P.O., Botstein D. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 2002, 13:1977-2000.
48. Szilagyi Z., Banyai G., Lopez M.D., McInerny C.J., Gustafsson C.M. Cyclin-dependent kinase 8 regulates mitotic commitment in fission yeast. Mol. Cell. Biol. 2012, 32:2099-2109.
49. Pasque V., Radzisheuskaya A., Gillich A., Halley-Stott R.P., Panamarova M., Zernicka-Goetz M., Surani M.A., Silva J.C. Histone variant macroH2A marks embryonic differentiation in vivo and acts as an epigenetic barrier to induced pluripotency. J. Cell Sci. 2012, 125:6094-6104.
50. Kapoor A., Goldberg M.S., Cumberland L.K., Ratnakumar K., Segura M.F., Emanuel P.O., Menendez S., Vardabasso C., Leroy G., Vidal C.I., Polsky D., Osman I., Garcia B.A., Hernando E., Bernstein E. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 2010, 468:1105-1109.
51. Larochelle S., Merrick K.A., Terret M.E., Wohlbold L., Barboza N.M., Zhang C., Shokat K.M., Jallepalli P.V., Fisher R.P. Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Mol. Cell 2007, 25:839-850.
52. Akoulitchev S., Chuikov S., Reinberg D. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 2000, 407:102-106.
53. Young R.A. Control of the embryonic stem cell state. Cell 2011, 144:940-954.
54. Doncic A., Falleur-Fettig M., Skotheim J.M. Distinct interactions select and maintain a specific cell fate. Mol. Cell 2011, 43:528-539.
55. Wong Sak Hoi J., Dumas B. Ste12 and Ste12-like proteins, fungal transcription factors regulating development and pathogenicity. Eukaryotic Cell 2010, 9:480-485.
56. Cullen P.J., Sprague G.F. The regulation of filamentous growth in yeast. Genetics 2012, 190:23-49.
57. Bao M.Z., Schwartz M.A., Cantin G.T., Yates J.R., Madhani H.D. Pheromone-dependent destruction of the Tec1 transcription factor is required for MAP kinase signaling specificity in yeast. Cell 2004, 119:991-1000.
58. Nelson C., Goto S., Lund K., Hung W., Sadowski I. Srb10/Cdk8 regulates yeast filamentous growth by phosphorylating the transcription factor Ste12. Nature 2003, 421:187-190.
59. Raithatha S., Su T.C., Lourenco P., Goto S., Sadowski I. Cdk8 regulates stability of the transcription factor Phd1 to control pseudohyphal differentiation of Saccharomyces cerevisiae. Mol. Cell. Biol. 2012, 32:664-674.
60. Dodgson J., Avula H., Hoe K.L., Kim D.U., Park H.O., Hayles J., Armstrong J. Functional genomics of adhesion, invasion, and mycelial formation in Schizosaccharomyces pombe. Eukaryotic Cell 2009, 8:1298-1306.
61. Linder T., Rasmussen N.N., Samuelsen C.O., Chatzidaki E., Baraznenok V., Beve J., Henriksen P., Gustafsson C.M., Holmberg S. Two conserved modules of Schizosaccharomyces pombe Mediator regulate distinct cellular pathways. Nucleic Acids Res. 2008, 36:2489-2504.
62. Adler A.S., McCleland M.L., Truong T., Lau S., Modrusan Z., Soukup T.M., Roose-Girma M., Blackwood E.M., Firestein R. CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency. Cancer Res. 2012, 72:2129-2139.
63. Tutter A.V., Kowalski M.P., Baltus G.A., Iourgenko V., Labow M., Li E., Kadam S. Role for Med12 in regulation of NANOG and NANOG target genes. J. Biol. Chem. 2009, 284:3709-3718.
64. Kagey M.H., Newman J.J., Bilodeau S., Zhan Y., Orlando D.A., van Berkum N.L., Ebmeier C.C., Goossens J., Rahl P.B., Levine S.S., Taatjes D.J., Dekker J., Young R.A. Mediator and cohesin connect gene expression and chromatin architecture. Nature 2010, 467:430-435.
65. Schneider E.V., Bottcher J., Blaesse M., Neumann L., Huber R., Maskos K. The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder. J. Mol. Biol. 2011, 412:251-266.
66. Knuesel M.T., Meyer K.D., Donner A.J., Espinosa J.M., Taatjes D.J. The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator. Mol. Cell. Biol. 2009, 29:650-661.
67. Lai F., Orom U.A., Cesaroni M., Beringer M., Taatjes D.J., Blobel G.A., Shiekhattar R. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 2013, 494:497-501.